Apr 2, 2020 · The prices detailed above are list prices—and the discrepancy between list prices and net prices due to rebates is likely partially responsible for high insulin prices, as detailed …

Mar 8, 2022 · New “generic” and “biosimilar” insulin products have come to market and the competition they provide – prices at roughly one-half of the brand name – has caused average …

Sep 26, 2024 · The agency concluded that “incentivizing manufacturers to inflate insulin list prices, restricting patients’ access to more affordable insulins on drug formularies, and shifting …

Apr 29, 2020 · Policymakers at the federal and state levels are actively considering policies to reduce costs for insulin patients.

Apr 6, 2020 · Eakinomics: Recent Trends in Insulin Prices Insulin was the poster child of the drug price wars in 2019 and early 2020, and the key facts are laid out in Insulin Cost and Pricing …

Mar 3, 2020 · Diabetes is one of the most burdensome diseases in America. This research gives an understanding of the insulin market in the United States.

Mar 11, 2022 · The BBBA would require all insulin products to have their price set by the Secretary of Health and Human Services (HHS)—as part of a larger proposal to have …

On September 20, 2024, the Federal Trade Commission (FTC) filed an administrative complaint against the three largest pharmacy benefit managers (PBMs) and their group purchasing …

Apr 2, 2020 · Diabetes is now the most expensive chronic disease in the United States, with one in every seven health care dollars spent on diabetes expenses. The rising cost of treating …

Apr 30, 2024 · Although these negotiations intend to lower drug list prices, the long-term outcome is likely reduced access to commonly used medications as well as increased prescription drug …